Summana The relationship between intrauterine device (IUD) use and risk of endometrial cancer has been analysed in a case-control study conducted in Italy between 1983 and 1992. including 453 patients with histologicallv confirmed endometrial cancer and 1.451 controls admitted for acute. non-gvnaecological. nonhormonal. non-neoplastic conditions to the same network of hospitals where cases had been identified. Two (0.40o) cases versus 36 (2.3%) controls reported ever using an IUD. The corresponding multivariate relative risk was 0.4 (9500 Cl 0.1 -1.0). The results of this study and the few published available epidemiological data suggest a protective role of IUD use on endometrial carcinogenesis. but potential selective mechanisms for IUD utilisation (indication bias) should be carefully considered in the interpretation.
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Intrauterine device (IUD) use may induce endometrial alterations. such as inflammatory changes (Sheppard, 1987 (Castellsague et al.. 1993) . To offer further data on the issue. we report the results from a case-control study conducted in Northern Italy (Parazzini et al.. 1991a ).
Patients and methods
The general design of this study has been previously described (Parazzini et al.. 1991a (Mantel & Haenszel. 1959) . In order to allow simultaneously for the effects of several potential confounding factors. unconditional multiple logistic regression. with maximum likelihood fitting. was used (Breslow & Day. 1980) . Included in the regression equations were terms for age and selected factors significantly associated in this data set with the risk of endometrial cancer (parity. Quetelet's index and oestrogen replacement therapy use).
Results
The distribution of cases and controls according to age and selected covanrates is presented in Table I . Cases were more frequently nulliparae (RR age adjusted. parae versus nullparae. 0.6: 95% CI 0.4-0.9). of higher body mass index (age adjusted RR. kg m--> 25 *s <25. 2.0: 95%0CI 1.7-2.4) and more often oestrogen replacement therapy users (RR ever versus never 2.0. 95% CI 1.3-3.1).
The relation between IUD use and endometrial cancer risk is considered in Table II biases. cases and controls were identified in institutions covering broadly comparable catchment areas, and participation was almost complete. Likewise. recall bias is unlikely.
since the interviewed cases and controls and the interviewers were unaware of the potential association between IUD use and endometrial cancer risk.
We did not have information on type of IUD used, thus we cannot evaluate the role of different types of IUD. particularly progestin-releasing ones. Despite these considerations, some biological evidence, the consistency of our results with data from the CASH study (Castellsague et al., 1993) and the magnitude of the association offer some support to the hypothesis that IUD use reduces the risk of endometrial cancer. The CASH study showed a decreased risk of endometrial cancer in IUD users of about 50%; in that study the risk tended to decrease with duration of use. offering some support to the hypothesis of a causal relationship, although the trend in risk with duration was not significant (Castellsague et al., 1993) .
In biological terms, laboratory and animal studies have suggested that IUD use may alter the response to steroids of the endometrium. These changes are mediated by the device itself as well as by the copper ions present in some devices. These alterations inhibit binding of oestrogen and progesterone to the endometrial cell receptors (Tamaya et al.. 1976 ) and decrease the steroid nuclear receptor concentration in the endometrial cells (Myatt et al., 1980) . These changes, however, may influence both oestrogen and progesterone activity, which have opposing effects on endometrial carcinogenesis (Parazzini et al., 1991b) .
In conclusion, the few available epidemiological data suggest a protective effect of IUD use on endometrial cancer risk, but potential indication or selection bias is difficult to overcome in any epidemiological study on the issue. and should therefore be carefully considered in the interpretation. 
